Motiksafortid etkileşimleri

Motiksafortid (Aphexda) için dizinlediğimiz FDA etiketlerinde ve bilgi sayfalarında 59 belgelenmiş etkileşim var: 0 majör, 59 orta, 0 minör ve bir etiketin anlamlı etkileşim olmadığını bildirdiği 0 çift. Aşağıdaki her kayıt, dayandığı cümleyi alıntılar. Bu ilaç sayfası bir başlangıç noktasıdır; sizin durumunuz için verilmiş bir hüküm değildir.

Etikete göre etkileşimler

Orta düzey etkileşimler (59)

  • Asebutololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Atenololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • AzelastinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Azelastin ve flutikazonantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Betaksololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Bisoprololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Brimonidin ve timololalfa adrenerjik agonistOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • DeksklorfeniraminantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • DesloratadinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • DifenhidraminantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • DimenhidrinatantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • DoksilaminantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Doksilamin ve piridoksinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Dorzolamid ve timololkarbonik anhidraz inhibitörüOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Esmololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • FamotidinH2 blokeriOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • FeksofenadinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Leukocytosis Administration of APHEXDA in conjunction with filgrastim increases circulating leukocytes as well as HSC populations. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • HidroksizinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • KarbinoksaminantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Karvedilolbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • KlemastinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • KlorfeniraminantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Labetalolbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • LevosetirizinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • LoratadinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • MeklizinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Metoprololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Nadololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Nebivololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • NizatidinH2 blokeriOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • OlopatadinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Olopatadin ve mometazonantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Pindololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • PrometazinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Propranololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • RanitidinH2 blokeriOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • SetirizinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • SimetidinH2 blokeriOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • SiproheptadinantihistaminikOrta

    Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Sotalolbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Timololbeta blokerOrta

    Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (Motiksafortid etiketi, Uyarılar ve önlemler)

  • Premedicate with an analgesic medication (e.g., acetaminophen) prior to each APHEXDA dose. (Motiksafortid etiketi, Uyarılar ve önlemler)

Kullandığınız her şeyi Motiksafortid ile karşılaştırın. Tüm listenizi ekleyin; her çift tek seferde kontrol edilir.

Sorgulama aracında aç

Tıbbi tavsiye değildir. Şiddet derecesi sizin koşullarınızı değil, etiketin ifadesini yansıtır. “Majör” işareti gözetim altında olağan bir uygulama olabilir, “minör” işareti ise yüksek dozlarda önem kazanabilir. Bir eczacıya danışın.